$MRK

1 thesis

bullish 0%neutral 0%bearish 100%

Avg return (1d)

—

Win rate (1d)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices delayed ~15 min · refreshed 1m ago

$MRKSEC Form 4bearish

DeLuca Richard R. · EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. · 21h agono track record yet

Sold 6,050 @ $130.38 avg · $788,773 · 2026-08-06

Form 4: DeLuca Richard R. sold MRK

DeLuca Richard R. (EVP&Pres, Merck Animal Heallth at Merck & Co., Inc.) reported an open-market sale of 6,050 shares of MRK at an average $130.38, roughly $788,773, in a Form 4 filed 2026-08-10.

Now $130.421m ago

1d—

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.